CSNPs can boost the efficiency of anticancer medications by improving chemotherapeutic delivery to cancer cells, drug uptake into tumor cells and drug accumulation, inhibiting MDR proteins such as P-gp, increasing drug bioavailability, and inducing apoptosis. This evidence concerns the gene PGP and neoplasm.